doi.org/10.1200/jco.20.02341

Other

Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes

David A. Sallman

,

,

..., Rami S. Komrokji

Journal of Clinical Oncology41.90

Volume: 39, Issue: 14, Pages: 1584 - 1594

Published: Jan 15, 2021

Paper Fields

Paper Details

Title

Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes

DOI

doi.org/10.1200/jco.20.02341

Published Date

Jan 15, 2021

Journal

Journal of Clinical Oncology

Volume

39

Issue

14

Pages

1584 - 1594

Notes

History